- Home
- BLDE vs NLSP Comparison
BLDE vs NLSP Comparison
Compare BLDE & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDE
- NLSP
- Stock Information
- Founded
- BLDE 2014
- NLSP 2015
- Country
- BLDE United States
- NLSP Switzerland
- Employees
- BLDE N/A
- NLSP N/A
- Industry
- BLDE Aerospace
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- BLDE Consumer Discretionary
- NLSP Health Care
- Exchange
- BLDE Nasdaq
- NLSP Nasdaq
- Market Cap
- BLDE 276.7M
- NLSP 243.8M
- IPO Year
- BLDE N/A
- NLSP 2021
- Fundamental
- Price
- BLDE $3.52
- NLSP $4.45
- Analyst Decision
- BLDE
- NLSP
- Analyst Count
- BLDE 0
- NLSP 0
- Target Price
- BLDE N/A
- NLSP N/A
- AVG Volume (30 Days)
- BLDE 527.4K
- NLSP 32.7K
- Earning Date
- BLDE 11-06-2024
- NLSP 10-18-2024
- Dividend Yield
- BLDE N/A
- NLSP N/A
- EPS Growth
- BLDE N/A
- NLSP N/A
- EPS
- BLDE N/A
- NLSP N/A
- Revenue
- BLDE $238,379,000.00
- NLSP N/A
- Revenue This Year
- BLDE $12.14
- NLSP N/A
- Revenue Next Year
- BLDE $11.35
- NLSP N/A
- P/E Ratio
- BLDE N/A
- NLSP N/A
- Revenue Growth
- BLDE 25.39
- NLSP N/A
- 52 Week Low
- BLDE $2.06
- NLSP $4.08
- 52 Week High
- BLDE $4.25
- NLSP $35.60
- Technical
- Relative Strength Index (RSI)
- BLDE 62.70
- NLSP 36.17
- Support Level
- BLDE $3.37
- NLSP $4.72
- Resistance Level
- BLDE $3.60
- NLSP $5.36
- Average True Range (ATR)
- BLDE 0.15
- NLSP 0.56
- MACD
- BLDE 0.05
- NLSP -0.01
- Stochastic Oscillator
- BLDE 89.87
- NLSP 19.79
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.